Today, Semler Scientific announced It has increased its Bitcoin ownership. It purchased 185 Bitcoins between May 23rd and June 3rd for $20m, with an average price of $107,974 each Bitcoin. Proceeds from the ATM program were used to purchase these Bitcoins.
“We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings,” Eric Semler is the Chairman of Semler Scientific. “And we are excited to launch the Semler Scientific dashboard today on our website to provide the public with regularly updated information on our bitcoin holdings and other key metrics.”
Semler raised $136.2 Million since April 2025 when it launched its ATM program. This was done through the sale of over 3.6 millions shares of common stock.
Semler will hold 4,449 shares of Semler by June 3, 2025. Bitcoin These bitcoins were purchased for $410.0 millions, an average of $92,158 each. The market value is approximately $446.2 millions at the time this article was written.
Eric Semler and X on a post “SMLR acquires 185 Bitcoins for $20 million and has generated BTC Yield of 26.7% YTD. Now holding 4,449 $BTC.”
Semler Scientific relies on the BTC Yield (KPI), as an indicator of performance, to evaluate the success of its Bitcoin strategy. BTC yield for the year to date is 26.7%.
“Semler Scientific believes this KPI can be used to supplement an investor’s understanding of Semler Scientific’s decision to fund the purchase of Bitcoin by issuing additional shares of its common stock or instruments convertible to common stock,” This form is 8K.
In Q1 FY2025, Semler Scientific reported a difficult quarter. In the first quarter of 2016, revenue dropped by 44% to $8.8million. Operating expenses increased to $39.9m from $8.9m last year. The main reason for this was the $29.8m contingent liability related to a potential settlement with DOJ. A $31.1 million loss was recorded, which is a significant difference from the $7.9 million profit reported in Q1 of 2024.
“Our healthcare business is seeing green shoots from the cardiovascular product line that we introduced to our large enterprise customer base this year,” said the CEO of Semler Scientific Doug Murphy-Chutorian. “We are expecting growth and cash generation from these FDA-cleared products and services, which will add to our bitcoin treasury strategy.”
“This article is not financial advice.”
“Always do your own research before making any type of investment.”
“ItsDailyCrypto is not responsible for any activities you perform outside ItsDailyCrypto.”
Source: bitcoinmagazine.com

